Pharma channel feed – Endpoints News

Pharma channel feed

BioPharma Solutions sold for $4B+ to two private equity firms

3 years ago

Catalent delays quarterly call as stock takes another dive

3 years ago

Viatris leans in on brand drug portfolio for future growth

3 years ago

'Practically impossible': On the difficulties of introducing new medicines across all 27 EU member states

3 years ago

Amgen and Entera Bio call off oral drug delivery partnership after four years

3 years ago

Eisai’s cancer drug Halaven at the center of $2B pact with BlissBio, like its Bristol Myers ADC deal

3 years ago

Ginkgo and Boehringer Ingelheim sign pact to mine microbes and find new molecules

3 years ago

Covid-19 public health emergencies are ending. What's changing?

3 years ago

How electronic health records evolved from digital tools to marketing strategy

3 years ago

Sandoz joins up with B2B pharma to commercialize six biosimilars in the US

3 years ago

With Eylea in decline, Regeneron awaits FDA approval for higher dose of blockbuster

3 years ago

FDA hits Novo Nordisk with CRL for its once-daily hemophilia drug concizumab

3 years ago

Covid drug and vaccine sales nosedive, denting biopharma revenue across the board

3 years ago

Novo Nordisk to restrict starter dose supply for weight loss drug Wegovy

3 years ago

It's IPO day for J&J's Kenvue: Stock gains 20% in first day of trading as unit raises $3.8B

3 years ago

Roche doubles down on organoids, human model systems with new research institute

3 years ago

Valneva, Pfizer delay their Lyme disease vaccine submission to 2026

3 years ago

Mirroring federal efforts, DeSantis signs new law on drug price transparency, PBM reforms

3 years ago

Amgen sues Sandoz to block biosimilar of blockbuster bone drug

3 years ago

Forge Biologics secures manufacturing and development deal with LabCorp

3 years ago

Pfizer to begin Haleon exit in coming months — report

3 years ago

FDA cites quality issues at Rentschler and Eli Lilly facilities

3 years ago

Biogen finally scores win in its fight to prevent copycats of MS drug in the EU

3 years ago

GSK RSV shot approved by FDA, starting next blockbuster vaccine race

3 years ago

First page Previous page 124 125 126127128 129 130 Next page Last page